NUREG-1556 Volume 13, Rev 2 - Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Commercial Radiopharmacy Licenses - Final Report: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 12: | Line 12: | ||
| document report number = NUREG V13 R2, NUREG-1556, Vol. 13, Rev. 2 | | document report number = NUREG V13 R2, NUREG-1556, Vol. 13, Rev. 2 | ||
| document type = NUREG | | document type = NUREG | ||
| volume number = 13 | |||
| page count = 289 | | page count = 289 | ||
}} | }} | ||
Revision as of 07:05, 24 April 2019
| ML19079A207 | |
| Person / Time | |
|---|---|
| Issue date: | 03/31/2019 |
| From: | Elliott R L, Gattone R G, Graham C, Katanic J F, McMurtray A C, Lizette Roldan-Otero, Thompson T Office of Nuclear Material Safety and Safeguards |
| To: | |
| Meyd, Donald | |
| References | |
| NUREG V13 R2, NUREG-1556, Vol. 13, Rev. 2 | |
| Download: ML19079A207 (289) | |